First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System

Syed Zaid, Guilherme F. Attizzani, Parasuram Krishnamoorthy, Sung Han Yoon, Luis A. Palma Dallan, Stanley Chetcuti, Shinichi Fukuhara, P. Michael Grossman, Sachin S. Goel, Marvin D. Atkins, Neal S. Kleiman, Rishi Puri, Beka Bakhtadze, Timothy Byrne, Akram W. Ibrahim, Kendra J. Grubb, Andy Tully, Howard C. Herrmann, Michela Faggioni, Basel RamlawiSahil Khera, Stamatios Lerakis, George D. Dangas, Annapoorna S. Kini, Samin K. Sharma, Michael J. Reardon, Gilbert H.L. Tang

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Background: The latest-generation Evolut FX TAVR system (Medtronic) offers several potential design improvements over its predecessors, but early reported experience has been limited. Objectives: This study sought to report our multicenter, limited market release, first-in-human experience of transcatheter aortic valve replacement (TAVR) with the Evolut FX system and compare it with a single-center PRO+ (Medtronic) experience. Methods: From June 27 to September 16, 2022, 226 consecutive patients from 9 US centers underwent transfemoral TAVR with the Evolut FX system for native aortic stenosis (89.4%) or prosthetic valve degeneration (10.6%). Commissural alignment was defined as 0° to 30° between native and FX commissures. Patient, anatomical, and procedural characteristics were retrospectively reviewed, and 30-day clinical and echocardiographic outcomes per Valve Academic Research Consortium-3 definitions were reported. Results: Of 226 patients, 34.1% were low risk, 4% had a bicuspid valve, and 11.5% had a horizontal root (≥60°). Direct Inline sheath (Medtronic) was used in 67.6% and Lunderquist stiff wire (Cook Medical) in 35.4% of cases. Optimal hat marker orientation during deployment was achieved in 98.4%, with commissural alignment in 96.5%. At 30 days, 14.3% mild, 0.9% moderate, and no severe paravalvular leak were observed. Compared with the Evolut PRO+ experience from 1 center, FX had a more symmetrical implantation with shallower depth at the left coronary cusp (P < 0.001), fewer device recaptures (26.1% vs 39.5%; P = 0.004), and improved commissural alignment (96.5% vs 80.2%; P < 0.001). Conclusions: The Evolut FX system demonstrated favorable 30-day outcomes with a significant improvement over PRO+ in achieving commissural alignment, fewer device recaptures, and more symmetrical implantation. These features may benefit younger patients undergoing TAVR with the supra-annular, self-expanding valve, where lifetime management would be important.

Original languageEnglish
Pages (from-to)1626-1635
Number of pages10
JournalJACC: Cardiovascular Interventions
Issue number13
StatePublished - 10 Jul 2023


  • Evolut FX
  • TAVR
  • commissural alignment


Dive into the research topics of 'First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System'. Together they form a unique fingerprint.

Cite this